Ls Investment Advisors, LLC Halozyme Therapeutics, Inc. Transaction History

Ls Investment Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$38.84 - $51.31 $345,093 - $455,889	-8,885 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$39.51 - $51.45 $65,665 - $85,509	-1,662 Reduced 15.76%	8,885 $370,000
Q4 2020 Feb 10, 2021	BUY	$25.81 - $43.62 $272,218 - $460,060	10,547 New	10,547 $450,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.83B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.